Search results
HPV vaccines prevent cancer in men and women, new research suggests — but fewer boys get the shots
NY Post via Yahoo News· 1 day agoNew research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer...
Woman's eye twitching, mystery symptoms lead to frightening diagnosis
TODAY via Yahoo News· 1 year agoWhat are warning signs of head and neck cancer? Woman was healthy when she began experiencing eye...
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, GSK Consumer Unit Spin-Off
Zacks via Yahoo Finance· 2 years agoThis week, J&J JNJ set in motion the second-quarter earnings season for the drug and biotech sector...
Wilmington's Smash Cancer tennis tournament receives national recognition
Star News via Yahoo News· 4 months agoA local tennis tournament committed to giving back has garnered national attention. Chris Tatum,...
Why Is Merck (MRK) Up 4.3% Since Last Earnings Report?
Zacks via Yahoo Finance· 9 months agoIt has been about a month since the last earnings report for Merck (MRK). Shares have added about...
Merck (MRK) Outpaces Industry YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoMerck’s MRK stock has risen 30.4% this year so far compared with an increase of 4.3% for the...
Q4 2023 PDS Biotechnology Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 months agoParticipants Tom Johnson; Director, Corporate Communications; LifeSci Advisors, LLC Frank Bedu-Addo; President, CEO & Director; PDS Biotechnology Corp Lars Boesgaard; Chief Financial Officer ...
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Zacks via Yahoo Finance· 1 year agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor, Keytruda,...
Merck & Co. (MRK) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Merck & Co. (NYSE: MRK) Q2 2022 Earnings Call Jul 28, 2022, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Q3 2023 Theriva Biologics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 months agoParticipants Steven A. Shallcross; CEO, CFO & Director; Theriva Biologics, Inc. Vince Wacher; Head of Corporate & Product Development; Theriva Biologics, Inc. James Molloy; Analyst; Alliance ...
